METABOLIC AND HEMODYNAMIC-EFFECTS OF MAGNESIUM SUPPLEMENTATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：48

作者：

ZEMEL, PC ^{[1
]}

ZEMEL, MB ^{[1
]}

URBERG, M ^{[1
]}

DOUGLAS, FL ^{[1
]}

GEISER, R ^{[1
]}

SOWERS, JR ^{[1
]}

机构：

[1] CIBA GEIGY CORP,DIV PHARMACEUT,SUMMIT,NJ 07901

来源：

AMERICAN JOURNAL OF CLINICAL NUTRITION | 1990年 / 51卷 / 04期

关键词：

Blood pressure; Cation metabolism; Lipids; Magnesium;

D O I：

10.1093/ajcn/51.4.665

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

The effect of magnesium supplementation on blood pressure, erythrocyte cation metabolism, and serum lipids was evaluated in 13 patients with mild hypertension. After randomization and a 3-wk placebo run-in period, seven patients received 40 mmol Mg asparate (20 mmol elemental Mg twice daily) and six received placebo for 3 mo. In comparison with placebo treatment, magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism. These results demonstrate that in magnesium-repleted hypertensive subjects, magnesium supplementation does not affect blood pressure or lipids probably because magnesium has no effect on cellular cation metabolism in magnesium-replete individuals.

引用

页码：665 / 669

页数：5

共 50 条

[21] FAMILIAL INFLUENCE UPON NACL SENSITIVITY IN PATIENTS WITH ESSENTIAL-HYPERTENSION
OSHIMA, T
MATSUURA, H
ISHIBASHI, K
KAINOUCHI, M
ISHIDA, T
OZONO, R
FUJII, T
KAJIYAMA, G
JOURNAL OF HYPERTENSION, 1992, 10 (09) : 1089 - 1094
[22] METABOLIC, HEMATOLOGICAL, AND CARDIAC EFFECTS OF LONG-TERM ISRADIPINE TREATMENT IN MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
MERIC, M
GOREN, T
ATILGAN, D
EREN, N
CUBUKCU, A
KOYLAN, N
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S58 - S60
[23] HUMORAL AND HEMODYNAMIC-EFFECTS OF IDRAPRIL CALCIUM, THE PROTOTYPE OF A NEW CLASS OF ACE-INHIBITORS, IN ESSENTIAL HYPERTENSIVE PATIENTS
TADDEI, S
GHIADONI, L
MATTEI, P
SUDANO, I
DURANTI, P
FAVILLA, S
VIRDIS, A
ROMAGNOLI, A
CRISCUOLI, M
COPPINI, A
SALVETTI, A
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (05) : 339 - 343
[24] Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension
Troughton, RW
Lewis, LK
Yandle, TG
Richards, AM
Nicholls, MG
HYPERTENSION, 2000, 36 (04) : 588 - 593
[25] URINARY CATECHOLAMINE RESPONSE TO GLUCAGON IN YOUNG AND ELDERLY PATIENTS WITH ESSENTIAL-HYPERTENSION
MANDAI, T
OGIHARA, T
HATA, T
OKADA, Y
OGASAHARA, S
MIKAMI, H
NAKAMARU, M
KUMAHARA, Y
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1980, 28 (10) : 462 - 465
[26] A comparison of the effects of lidocaine or magnesium sulfate on hemodynamic response and QT dispersion related with intubation in patients with hypertension
Kiraci, G.
Demirhan, A.
Tekelioglu, U. Y.
Akkaya, A.
Bilgi, M.
Erdem, A.
Bayir, H.
Yildiz, I.
Kocoglu, H.
ACTA ANAESTHESIOLOGICA BELGICA, 2014, 65 (03) : 81 - 86
[27] Acute antihypertensive effects of calcium channel blockers are not affected by calcium supplementation in patients with essential hypertension
Sato, K
Dohi, Y
Miyagawa, K
Kojima, M
JAPANESE HEART JOURNAL, 1998, 39 (03): : 347 - 353
[28] Effects of vitamin C supplementation on blood pressure and hypertension control in response to ambient temperature changes in patients with essential hypertension
Yuan, Xiaojie
Li, Xiaochun
Ji, Zhaohua
Xiao, Jing
Zhang, Lei
Zhang, Weilu
Su, Haixiao
Kaliannan, Kanakaraju
Long, Yong
Shao, Zhongjun
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2019, 41 (05) : 414 - 421
[29] EFFECT OF NIFEDIPINE MONOTHERAPY ON PLATELET-AGGREGATION IN PATIENTS WITH UNTREATED ESSENTIAL-HYPERTENSION
OSMIALOWSKA, Z
NARTOWICZSLONIEWSKA, M
SLOMINSKI, JM
KRUPAWOJCIECHOWSKA, B
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (04) : 403 - 404
[30] EFFICACY AND TOLERABILITY OF LISINOPRIL COMPARED WITH EXTENDED RELEASE FELODIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
JENSEN, HA
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1992, 14 (06) : 1095 - 1110

← 1 2 3 4 5 →